Copyright

(c) 2010-2024 Jon L Gelman, All Rights Reserved.
Showing posts with label testing. Show all posts
Showing posts with label testing. Show all posts

Wednesday, January 5, 2022

Innovation is Necessary to Meet the Challenge of COVID in 2022

COVID is the most extensive occupational exposure event in the history of the United States. Workplaces are now primed for a massive wave of compensation claims due to the Omicron variant. A recent study provides a potential opportunity for employers and insurance companies to reduce their risk exposure through early sequencing and treatment proactively.

Friday, September 4, 2020

Workplace Testing - Pandemic Preparedness Strategy for Success

Maintaining a safe workplace is a crucial strategy in the era of COVID-19. Today's guest author, Michael Gelman, MD PhD, discusses how testing can play a critical role going forward.

A lot of people are getting very excited about Michael Mina’s proposed strategy of cheap, rapid, frequent testing. From his Op-Ed in the Times, to his appearance on TWiV, to this article in the Atlantic, there’s a lot of hope around the potential for inexpensive antigen tests, like the Abbott BinaxNow - which quickly got bought up by the Department of Health and Human Services through December’s anticipated production. It’s possible that another company funded by a U.S. Government initiative might come out with something as good, or better, in the near future. (And no, I don’t have any inside information on any of this. Not that I haven’t asked around.) All this comes amid the CDC’s controversial revision of its testing guidelines, as well as a recent FDA statement that points out the unknowns around repurposing a test, which was originally developed for diagnosis, to screen large numbers of asymptomatic persons. Meanwhile, another Times article points out what many of us have known for months: that a positive PCR test late in the course of illness may be more of a hindrance than a help. 

Saturday, June 20, 2020

Employers Can't Compel COVID-19 Antibody Testing

CDC said in its Interim Guidelines that antibody test results “should not be used to make decisions about returning persons to the workplace.” In light of this CDC guidance, under the ADA may an employer require antibody testing before permitting employees to re-enter the workplace? (6/17/20)

Wednesday, May 13, 2020

NJ Health Commissioner Orders COVID-19 Testing in all Long-Term Care Facilities

NJ is implementing mandatory testing requirements for all staff and residents of nursing homes. The new testing requirement will establish objective evidence as to the existence of the COVID-19 infection to both essential workers and residents in nursing homes.